An Applicator Delivery System for Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Topical Suspension (Gel): Innovating Psoriasis Vulgaris Treatment Through Patient Collaboration
Crossref DOI link: https://doi.org/10.1007/s13555-015-0087-0
Published Online: 2015-11-05
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rasmussen, Gritt
Bech, Lene Lillevang
Nielsen, Torben Wager
Funding for this research was provided by:
LEO Pharma